Luly Jay R. - Insider Non-Derivative Transactions at ENANTA PHARMACEUTICALS INC (ENTA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 5, 2025, Luly Jay R.'s relationship to ENANTA PHARMACEUTICALS INC (ENTA) is Director,Officer (President and CEO), and currently has 858,026 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ENTA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Luly Jay R. - Insider Non-Derivative Transactions of ENTA Common Stock

Luly Jay R. - Insider Non-Derivative Transactions at ENTA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 6, 2025	Sell -- (Common Stock)	4743	14.23	858026
Dec 2, 2025	F -- (Common Stock)	1885	14.12	862769
Feb 13, 2025	P -- (Common Stock)	45000	5.69	846638
Feb 13, 2025	F -- (Common Stock)	7484	5.59	864654
Feb 13, 2025	Acquisition -- (Common Stock)	25500	0	872138
Dec 7, 2024	Sell -- (Common Stock)	5142	8.06	801638
Dec 2, 2024	F -- (Common Stock)	3829	8.6	806780
Feb 13, 2024	F -- (Common Stock)	1584	12.41	810609
Feb 13, 2024	Acquisition -- (Common Stock)	5400	0	812193
Dec 6, 2023	Sell -- (Common Stock)	7230	9.63	806793
Dec 2, 2023	F -- (Common Stock)	5787	9.49	814023
Mar 14, 2023	Sell -- (Common Stock)	1566	46.13	819810
Mar 14, 2023	Sell -- (Common Stock)	15649	45.31	821376
Mar 14, 2023	Sell -- (Common Stock)	10697	44.81	837025
Mar 14, 2023	M -- (Common Stock)	27912	14	847722
Feb 14, 2023	F -- (Common Stock)	20591	52.77	799219
Feb 14, 2023	Acquisition -- (Common Stock)	15285	0	803590
Feb 14, 2023	Acquisition -- (Common Stock)	22950	0	811255
Feb 14, 2023	F -- (Common Stock)	20591	52.77	819810
Feb 14, 2023	Acquisition -- (Common Stock)	16220	0	819810
Feb 14, 2023	Acquisition -- (Common Stock)	29146	0	840401